(Q37627544)

21 August 2017

1 reference

title

Transporter pharmacogenetics and statin toxicity (English)

1 reference

21 August 2017

M Niemi

1

0 references

language of work or name

English

0 references

publication date

4 November 2009

1 reference

Clinical Pharmacology & Therapeutics

21 August 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

21 August 2017

volume

87

1 reference

21 August 2017

issue

1

1 reference

21 August 2017

page(s)

130-133

1 reference

Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Global analysis of genetic variation in SLCO1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Human hepatobiliary transport of organic anions analyzed by quadruple-transfected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Effect of OATP1B1 (SLCO1B1) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Evaluation of inhibitory drug interactions during drug development: genetic polymorphisms must be considered

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

SLCO1B1 variants and statin-induced myopathy--a genomewide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

21 January 2018

ABCG2: a perspective.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

ABCB1 haplotypes differentially affect the pharmacokinetics of the acid and lactone forms of simvastatin and atorvastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

inferred from DOI database lookup

7 January 2021

based on heuristic

Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.197

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2009.197

1 reference

21 August 2017

1 reference